New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones

Vaccine

Volumn 20, Issue 9-10, 2002, Pages 1281-1289

  Begum, Nurjahan ^a   Horiuchi, Sankichi ^a   Tanaka, Yuetsu ^b   Yamamoto, Norio ^a   Ichiyama, Kouji ^a   Yamamoto, Naoki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Antibody; Mimotope; Phage clones; T cell leukemia virus type I

Indexed keywords

AMINO ACID; COAT PROTEIN; ENVELOPE PROTEIN; EPITOPE; GLYCOPROTEIN GP 46; HUMAN T CELL LEUKEMIA VIRUS ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LAT 27; NEUTRALIZING ANTIBODY; PEPTIDE LIBRARY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOASSAY; IMMUNOGENICITY; METHODOLOGY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SERODIAGNOSIS; STAINING; VIRUS ENVELOPE;

ANIMALS; ANTIBODIES, MONOCLONAL; DELTARETROVIRUS ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNIZATION; NEUTRALIZATION TESTS; PEPTIDE LIBRARY; RABBITS; SEQUENCE ALIGNMENT; VIRAL VACCINES;

EID: 0037203924     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00478-9     Document Type: Article

References (23)

1. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
2. Adult T-cell leukemia: Antigen in adult T-cell line and detection of antibodies to the antigen in human sera
3. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease
4. HTLV-I associated myelopathy, a new clinical entity
5. Isolation of an HTLV-I-like retrovirus from patients with tropical spastic paraparesis
6. Adult T-cell leukemia associated antigen (ATLA): Detection of a glycoprotein in cell and virus-free supernatant
7. Human T-cell leukemia virus associated membrane antigens (HTLV-MA): Identity of the major antigens recognized following virus infection
8. Sera from adult T-cell leukemia patients react with envelope and core polypeptides of adult T-cell leukemia virus
9. Identification of gag and env gene products of human T-cell leukemia virus (HTLV)
10. Envelope proteins of human T-cell leukemia virus: Expression in Escherichia coli and its application to studies of env gene functions
11. Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type I by immunization with viral env gene products produced in Escherichia coli
12. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection
13. Mapping of immunogenic regions of human T-cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp 46
14. Detection of antibodies to human T-lymphotropic virus type-I by using synthetic peptides
15. Antibody reactivity to different regions of human T-cell leukemia virus type I gp61 in infected people
16. Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia lymphotropic virus type I
17. Identification of a neutralization epitope on the envelope gp46 of T-cell leukemia virus type I and induction of neutralizing antibody by peptide immunization
18. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposed vector
19. Libraries of peptides and proteins displayed on filamentous phage
20. Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type I (HTLV-I)
21. Identifcation of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1
22. Immunisation with phage displaying peptides representing single epitopes of the glycoproteins G can give rise to partial protective immunity to HSV-2
23. Effect of immunization on HTLV-I infection in rabbits